Federal Drug Pricing Transparency Efforts Outpace State Laws Requiring Drug Manufacturer Price Reporting for the First Half of 2019
By EsqSocial Corporation 20/12/19
During 2017 and 2018, states took the reins in terms of enacting laws compelling drug manufacturers to disclose drug pricing. State activity has slowed during the first six months of 2019. Instead, during the first half of 2019, the federal...
By: Blank Rome LLP